Dona Sinha

10PUBLICATIONS
6CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGroundwater quality processes and contaminated land assessmentChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Dec 30, 2025
Seasonal impact of PM<sub>2.5</sub> on pro-oncogenic drivers among participants of a thermal power plant in India.

Sukanya Ghosh, Rupa Chaudhuri, Meghna Mukherjee

|Jan 20, 2024
The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review.

Rupa Chaudhuri, Anurima Samanta, Priyanka Saha

|Aug 12, 2023
Targeting Cell Signaling Pathways in Lung Cancer by Bioactive Phytocompounds.

Neeraj Choudhary, Sweta Bawari, Jack T Burcher

|Aug 31, 2022
Influence of differential arsenic exposure on cellular redox homeostasis of exposed rural women of West Bengal.

Priyanka Prasad, Sushant Kumar Singh, Sukanya Ghosh

|Feb 26, 2022
Low dose epigallocatechin-3-gallate revives doxorubicin responsiveness by a redox-sensitive pathway in A549 lung adenocarcinoma cells.

Suchisnigdha Datta, Dona Sinha

|Oct 16, 2021
Impact of anesthetics on oncogenic signaling network: a review on propofol and isoflurane.

Priyanka Saha, Ananya Das, Nabanita Chatterjee

Pageof 2